Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial

Jesper Kjærgaard; Nina Marie Birk; Thomas N Nissen; Lisbeth Marianne Thøstesen; Gitte Thybo Pihl; Christine S Benn; Dorthe L Jeppesen; Ole Pryds; Poul-Erik Kofoed; Peter Aaby; Gorm Greisen; Lone G Stensballe

doi:10.1038/pr.2016.142

Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial

Jesper Kjærgaard, Nina Marie Birk, Thomas N Nissen, Lisbeth Marianne Thøstesen, Gitte Thybo Pihl, Christine S Benn, Dorthe L Jeppesen, Ole Pryds, Poul-Erik Kofoed, Peter Aaby, Gorm Greisen, Lone G Stensballe

25 Citations (Scopus)

Abstract

BACKGROUND: Childhood infections are common and Bacillus Calmette-Guérin (BCG) vaccination at birth may prevent these via nonspecific effects.

METHODS: A randomized, clinical multicenter trial. All women planning to give birth (n = 16,521) at the three study sites were invited during the recruitment period. Participating children were randomized to receive BCG within 7 d of birth or to a no intervention control group. Parent-reported infections (events) were collected using telephone interviews at 3 and 13 mo. Data collectors were blinded to allocation.

RESULTS: The analyses included 4,224/4,262 (99%) and 4,192/4,262 (98%) children at 3 and 13 mo. From 0 to 3 mo, there were 291 events in the BCG group vs. 336 events in the control group, incidence rate ratio (IRR) = 0.87 (95% confidence interval (CI): 0.72 to 1.05). In this age group, the IRR was 0.62 (95% CI: 0.39 to 0.98) if the mother was BCG vaccinated. From 3 to 13 mo, there were 7,028 vs. 6,791 events, IRR = 1.02 (95% CI: 0.97 to 1.07).

CONCLUSION: This study did not find a nonspecific public health benefit of BCG on parent-reported infections. BCG may have reduced the incidence of infections in children of BCG-vaccinated mothers during the first 3 mo.

Original language	English
Journal	Pediatric Research
Volume	80
Issue number	5
Pages (from-to)	681-685
Number of pages	5
ISSN	0031-3998
DOIs	https://doi.org/10.1038/pr.2016.142
Publication status	Published - 1 Nov 2016

Keywords

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/pr.2016.142

pr2016142.pdfFinal published version, 195 KB

Cite this

Kjærgaard, J., Birk, N. M., Nissen, T. N., Thøstesen, L. M., Pihl, G. T., Benn, C. S., Jeppesen, D. L., Pryds, O., Kofoed, P-E., Aaby, P., Greisen, G., & Stensballe, L. G. (2016). Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial. Pediatric Research, 80(5), 681-685. https://doi.org/10.1038/pr.2016.142

@article{2989f4fc67654a4bb0d6071061ee9df6,

title = "Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial",

abstract = "BACKGROUND: Childhood infections are common and Bacillus Calmette-Gu{\'e}rin (BCG) vaccination at birth may prevent these via nonspecific effects.METHODS: A randomized, clinical multicenter trial. All women planning to give birth (n = 16,521) at the three study sites were invited during the recruitment period. Participating children were randomized to receive BCG within 7 d of birth or to a no intervention control group. Parent-reported infections (events) were collected using telephone interviews at 3 and 13 mo. Data collectors were blinded to allocation.RESULTS: The analyses included 4,224/4,262 (99%) and 4,192/4,262 (98%) children at 3 and 13 mo. From 0 to 3 mo, there were 291 events in the BCG group vs. 336 events in the control group, incidence rate ratio (IRR) = 0.87 (95% confidence interval (CI): 0.72 to 1.05). In this age group, the IRR was 0.62 (95% CI: 0.39 to 0.98) if the mother was BCG vaccinated. From 3 to 13 mo, there were 7,028 vs. 6,791 events, IRR = 1.02 (95% CI: 0.97 to 1.07).CONCLUSION: This study did not find a nonspecific public health benefit of BCG on parent-reported infections. BCG may have reduced the incidence of infections in children of BCG-vaccinated mothers during the first 3 mo.",

keywords = "Journal Article",

author = "Jesper Kj{\ae}rgaard and Birk, {Nina Marie} and Nissen, {Thomas N} and Th{\o}stesen, {Lisbeth Marianne} and Pihl, {Gitte Thybo} and Benn, {Christine S} and Jeppesen, {Dorthe L} and Ole Pryds and Poul-Erik Kofoed and Peter Aaby and Gorm Greisen and Stensballe, {Lone G}",

year = "2016",

month = nov,

day = "1",

doi = "10.1038/pr.2016.142",

language = "English",

volume = "80",

pages = "681--685",

journal = "Pediatric Research",

issn = "0031-3998",

publisher = "nature publishing group",

number = "5",

}

TY - JOUR

T1 - Nonspecific effect of BCG vaccination at birth on early childhood infections

T2 - a randomized, clinical multicenter trial

AU - Kjærgaard, Jesper

AU - Birk, Nina Marie

AU - Nissen, Thomas N

AU - Thøstesen, Lisbeth Marianne

AU - Pihl, Gitte Thybo

AU - Benn, Christine S

AU - Jeppesen, Dorthe L

AU - Pryds, Ole

AU - Kofoed, Poul-Erik

AU - Aaby, Peter

AU - Greisen, Gorm

AU - Stensballe, Lone G

PY - 2016/11/1

Y1 - 2016/11/1

N2 - BACKGROUND: Childhood infections are common and Bacillus Calmette-Guérin (BCG) vaccination at birth may prevent these via nonspecific effects.METHODS: A randomized, clinical multicenter trial. All women planning to give birth (n = 16,521) at the three study sites were invited during the recruitment period. Participating children were randomized to receive BCG within 7 d of birth or to a no intervention control group. Parent-reported infections (events) were collected using telephone interviews at 3 and 13 mo. Data collectors were blinded to allocation.RESULTS: The analyses included 4,224/4,262 (99%) and 4,192/4,262 (98%) children at 3 and 13 mo. From 0 to 3 mo, there were 291 events in the BCG group vs. 336 events in the control group, incidence rate ratio (IRR) = 0.87 (95% confidence interval (CI): 0.72 to 1.05). In this age group, the IRR was 0.62 (95% CI: 0.39 to 0.98) if the mother was BCG vaccinated. From 3 to 13 mo, there were 7,028 vs. 6,791 events, IRR = 1.02 (95% CI: 0.97 to 1.07).CONCLUSION: This study did not find a nonspecific public health benefit of BCG on parent-reported infections. BCG may have reduced the incidence of infections in children of BCG-vaccinated mothers during the first 3 mo.

AB - BACKGROUND: Childhood infections are common and Bacillus Calmette-Guérin (BCG) vaccination at birth may prevent these via nonspecific effects.METHODS: A randomized, clinical multicenter trial. All women planning to give birth (n = 16,521) at the three study sites were invited during the recruitment period. Participating children were randomized to receive BCG within 7 d of birth or to a no intervention control group. Parent-reported infections (events) were collected using telephone interviews at 3 and 13 mo. Data collectors were blinded to allocation.RESULTS: The analyses included 4,224/4,262 (99%) and 4,192/4,262 (98%) children at 3 and 13 mo. From 0 to 3 mo, there were 291 events in the BCG group vs. 336 events in the control group, incidence rate ratio (IRR) = 0.87 (95% confidence interval (CI): 0.72 to 1.05). In this age group, the IRR was 0.62 (95% CI: 0.39 to 0.98) if the mother was BCG vaccinated. From 3 to 13 mo, there were 7,028 vs. 6,791 events, IRR = 1.02 (95% CI: 0.97 to 1.07).CONCLUSION: This study did not find a nonspecific public health benefit of BCG on parent-reported infections. BCG may have reduced the incidence of infections in children of BCG-vaccinated mothers during the first 3 mo.

KW - Journal Article

U2 - 10.1038/pr.2016.142

DO - 10.1038/pr.2016.142

M3 - Journal article

C2 - 27429204

SN - 0031-3998

VL - 80

SP - 681

EP - 685

JO - Pediatric Research

JF - Pediatric Research

IS - 5

ER -

Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this